ANI Pharmaceuticals Depreciation & Amortization 2011-2026 | ANIP

Annual Depreciation & Amortization ANI Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
67.7 M	59.8 M	57 M	47.3 M	44.6 M	44.6 M	33.7 M	27.9 M	22.3 M	6.9 M	3.88 M	1.11 M	567 K	148 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
67.7 M	148 K	29.8 M

Quarterly Depreciation & Amortization ANI Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.6 M	23.3 M	22.9 M	15.7 M	14.7 M	14.7 M	15.2 M	14.7 M	14.7 M	-	14.2 M	13.8 M	14.6 M	-	11.3 M	11.3 M	10.9 M	-	11.4 M	11.2 M	11.2 M	-	9.47 M	9.47 M	16.1 M	-	8.55 M	8.31 M	8.2 M	-	7.1 M	7.1 M	6.71 M	-	5.97 M	5.96 M	4.61 M	-	2.05 M	1.42 M	1.33 M	-	1.19 M	706 K	703 K	-	382 K	147 K	145 K	-	144 K	141 K	30.9 K	-	35.7 K	40.5 K	41.9 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
23.3 M	30.9 K	8.32 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Amarin Corporation plc AMRN	200 K	$ 14.8	0.34 %	$ 6.03 B	Irlanda
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.87	6.7 %	$ 4.74 M	China
Adagene ADAG	723 K	$ 2.63	-1.5 %	$ 148 M	China
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Cabaletta Bio CABA	1.43 M	$ 2.59	5.94 %	$ 3.03 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.55	6.29 %	$ 9.9 B	Israel
Autolus Therapeutics plc AUTL	7.55 M	$ 1.46	-0.1 %	$ 373 M	Britain
Amneal Pharmaceuticals AMRX	62.6 M	$ 14.52	-	$ 4.49 B	USA
Codexis CDXS	4.95 M	$ 1.29	0.01 %	$ 94.7 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel